Variation of risks of breast and ovarian cancer associated with different germline mutations of the BRCA2 gene

Nature Genetics

Volumn 15, Issue 1, 1997, Pages 103-105

  Gayther, Simon A ^a   Mangion, Jonathon ^b   Russell, Paul ^a   Seal, Sheila ^b   Barfoot, Rita ^b   Ponder, Bruce A J ^a   Stratton, Michael R ^b   Easton, Douglas ^c  

^a ADDENBROOKE S HOSPITAL   (United Kingdom)

^b INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BREAST CANCER; CANCER RISK; CANCER SUSCEPTIBILITY; CHROMOSOME 13Q; DELETION MUTANT; EXON; FRAMESHIFT MUTATION; GENE MUTATION; GENOTYPE; GERM LINE; HUMAN; OVARY CANCER; PANCREAS CANCER; PHENOTYPE; PRIORITY JOURNAL; PROSTATE CANCER;

BRCA2 PROTEIN; BREAST NEOPLASMS; DNA MUTATIONAL ANALYSIS; FEMALE; FRAMESHIFT MUTATION; GENETIC PREDISPOSITION TO DISEASE; GERM-LINE MUTATION; HUMANS; MALE; NEOPLASM PROTEINS; OVARIAN NEOPLASMS; RISK FACTORS; TRANSCRIPTION FACTORS;

EID: 0031012305     PISSN: 10614036     EISSN: None     Source Type: Journal    
DOI: 10.1038/ng0197-103     Document Type: Article

References (16)

1. Wooster, R. et al. Identification of the breast-cancer susceptibility gene BRCA2. Nature 378, 789-792 (1995).
2. Wooster, R. et al. Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12-13. Science 265, 2088-2090 (1994).
3. Thorlacius, S. et al. A single BRCA2 mutation in male and female breast-cancer families from Iceland with varied cancer phenotypes. Nature Genet. 13, 117-119 (1996).
4. Phelan, C.M. et al. Mutation analysis of the BRCA2 gene in 49 site-specific breast-cancer families Nature Genet. 13, 120-122 (1996).
5. Miki, Y. et al. A strong candidate for the breast and ovarian-cancer susceptibility gene BRCA1. Science 266, 66-71 (1994).
6. Easton, D.F., Bishop, D.T., Ford, D., Crockford, G.P. & the Breast Cancer Linkage Consortium. Genetic linkage analysis in familial breast and ovarian cancer. Am. J. Hum. Genet. 52, 718-722 (1993).
7. Gayther, S.A. et al. Germline mutations of the BRCA1 gene in breast and ovarian-cancer families provide evidence for a genotype-phenotype correlation. Nature Genet. 11, 428-433 (1995).
8. Holt, J.T. et al. Growth-retardation and tumor-inhibition by BRCA1. Nature Genet. 12, 298-302 (1996).
9. Gayther, S.A. et al. Rapid detection of regionally clustered germ-line BRCA1 mutations by multiplex heteroduplex analysis. Am. J. Hum. Genet. 58, 451-456 (1996).
10. Tavtigian, S.V. et al. The complete BRCA2 gene and mutations in chromosome 13q-linked kindreds. Nature Genet. 12, 333-337 (1996).
11. Mazoyer, S. et al. A polymorphic stop codon in BRCA2. Nature Genet. 14, 253-254 (1996).
12. Couch, F.J. et al. BRCA2 germline mutations in male breast-cancer cases and breast-cancer families. Nature Genet. 13, 123-125 (1996).
13. Neuhausen, S. et al. Recurrent BRCA2 6174delT mutations in Ashkenazi Jewish women affected by breast-cancer. Nature Genet. 13, 126-128 (1996).
14. Nagase, H. et al. Correlation between the location of germ-line mutations in the APC gene and the number of colorectal polyps in familial adenomatous polyposis patients. Cancer Res. 52, 4055-4057 (1992).
15. Gayther S.A. et al. Regionally clustered APC mutations are associated with a severe phenotype and occur at a high frequency in new mutation cases of adenomatous polyposis coli. Hum. Mol. Genet. 3, 53-56 (1994).
16. Spirio, L. et al. Alleles of the APC gene: an attenuated form of familial polyposis. Cell 75, 951-957 (1993).